Graphite Bio

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Graphite Bio and other ETFs, options, and stocks.

About GRPH

Graphite Bio, Inc. operates as a clinical-stage gene editing company. It focuses on therapies that harness targeted gene integration to treat or cure serious diseases. 

CEO
Joshua Lehrer-Graiwer
CEOJoshua Lehrer-Graiwer
Employees
Employees
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
2017
Founded2017
Employees
Employees

GRPH Key Statistics

Market cap
181.62M
Market cap181.62M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
227.30K
Average volume227.30K
High today
$3.23
High today$3.23
Low today
$3.00
Low today$3.00
Open price
$3.00
Open price$3.00
Volume
59.23K
Volume59.23K
52 Week high
$17.13
52 Week high$17.13
52 Week low
$2.07
52 Week low$2.07

Analyst ratings

71%

of 7 ratings
Buy
71.4%
Hold
28.6%
Sell
0%

GRPH Earnings

-$3.45
-$2.30
-$1.15
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 9, After Hours
ActualExpected Nov 9, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.